Related Experiment Video
Updated: Jun 16, 2026

Growing a Cystic Fibrosis-Relevant Polymicrobial Biofilm to Probe Community Phenotypes
Published on: April 19, 2024
Molecular epidemiology of Staphylococcus aureus in pediatric cystic fibrosis patients: a single-center study
Katarzyna Garbacz1, Lidia Piechowicz2, Aneta Mroczkowska3
1Department of Oral Microbiology, Medical Faculty, Medical University of Gdansk, Gdansk, Poland.
Insights
Staphylococcus aureus respiratory infections in pediatric cystic fibrosis patients show diverse spa types, with macrolide resistance common in adolescents. Individualized colonization patterns suggest limited clonal spread, necessitating careful monitoring of antibiotic resistance.
Area of Science:
- Microbiology
- Pediatric Pulmonology
- Infectious Diseases
Background:
- Staphylococcus aureus is a significant respiratory pathogen in children with cystic fibrosis (CF).
- Understanding the diversity and relatedness of S. aureus strains is crucial for managing CF patients.
- Assessing antimicrobial resistance patterns is essential for effective treatment strategies.
Purpose of the Study:
- To determine the prevalence and relatedness of Staphylococcus aureus spa types in pediatric CF patients.
- To analyze S. aureus isolates based on patient age groups.
- To evaluate the antimicrobial resistance profiles of these isolates.
Main Methods:
- Analysis of 165 S. aureus isolates from 82 pediatric CF patients over three years.
- Molecular typing including spa typing and SCCmec typing.
- Antimicrobial susceptibility testing was performed.
Main Results:
- Sixty-four spa types were identified, including five novel types, with common clonal complexes (CC30, CC22, CC97, CC45, CC15).
- Most patients (67.1%) harbored a single spa type, indicating individualized colonization.
- High rates of macrolide (67.4%) and lincosamide (60.9%) resistance were observed, especially in adolescents (12-18 years).
- Methicillin-resistant Staphylococcus aureus (MRSA) was found in 10.7% of patients, exclusively with monoclonal colonization.
Conclusions:
- Staphylococcus aureus colonization in pediatric CF patients is highly diverse and predominantly individualized.
- Limited evidence of clonal transmission suggests distinct infection dynamics.
- High macrolide resistance, particularly in adolescents, warrants careful monitoring of macrolide therapy and periodic microbiological surveillance to prevent further resistance selection.
Introduction:
Staphylococcus aureus is a key respiratory pathogen in children with cystic fibrosis (CF). This study aimed to evaluate the prevalence and relatedness of spa types of S. aureus respiratory isolates from pediatric CF patients, grouped by age, and to assess their antimicrobial resistance.
Methods:
A total of 165 S. aureus isolated from 82 patients from single-center and diagnosed with cystic fibrosis over a three-year period were analyzed. Molecular typing (spa typing and SCCmec typing) and antimicrobial susceptibility testing were performed.
Results:
Sixty-four spa types were identified, including five novel types, and the isolates were assigned to 11 multilocus sequence typing (MLST) clonal complexes, most frequently CC30, CC22, CC97, CC45, and CC15. In 67.1% of patients, only a single spa type was detected. In cases where multiple types were isolated from a single patient, 85.2% of the isolates were not clonally related. Macrolide and lincosamide resistance was common, particularly among adolescents aged 12-18 years, at rates of 67.4% and 60.9%, respectively. Resistance to fluoroquinolones, aminoglycosides, tetracyclines, and co-trimoxazole did not exceed 15%. MRSA was detected in 10.7% of patients and exclusively among those with monoclonal colonization.
Conclusion:
The finding indicates that S. aureus colonization in pediatric CF patients is highly diverse and primarily individualized, with limited evidence of clonal transmission. Given the high prevalence of macrolide resistance-particularly among adolescents-long-term macrolide therapy should be carefully monitored, with periodic microbiological surveillance to mitigate resistance selection.
Related Concept Videos
Staphylococcal Skin Infections
Clinical Significance of Antibiotic Resistance
Cystic Fibrosis: Pathogenesis
CF is primarily caused by a genetic mutation in a chromosome 7 gene coding for the cystic fibrosis transmembrane conductance regulator (CFTR) protein. The most common gene mutation leading to CF is the ΔF508 mutation, but...
Mechanism of Antibiotic Resistance in MRSA
